Nitric oxide relaxes rat tail artery smooth muscle by cyclic GMP-independent decrease in calcium sensitivity of myofilaments

Cell Calcium

Volumn 36, Issue 2, 2004, Pages 165-173

  Soloviev, A ^a   Lehen'kyi, V ^a   Zelensky, S ^a   Hellstrand, P ^b  

^a STATE INSTITUTION NATIONAL RESEARCH CENTER FOR RADIATION MEDICINE OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE   (Ukraine)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Cyclic guanosine monophosphate; Intracellular free calcium level; Myofilament calcium sensitivity; Nitric oxide; NO donors; Soluble guanylyl cyclase

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 6 ANILINO 5,8 QUINOLINEQUINONE; ALPHA TOXIN; BETA ESCIN; CALCIUM ION; CYCLIC GMP; DITHIOERYTHRITOL; GLYCERYL TRINITRATE; GUANYLATE CYCLASE INHIBITOR; HEPTAPEPTIDE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITROPRUSSIDE SODIUM; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; POTASSIUM CHLORIDE; THIOL GROUP; TRITON X 100;

ANIMAL CELL; ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; ATTENUATION; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL TONE; CALCIUM CELL LEVEL; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; ENDOTHELIUM; ENZYME ACTIVATION; ISOLATION PROCEDURE; MALE; MUSCLE FORCE; MUSCLE TONE; MYOFILAMENT; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TAIL ARTERY; VASCULAR SMOOTH MUSCLE;

EID: 3242666332     PISSN: 01434160     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceca.2004.02.002     Document Type: Article

References (26)

1. 2+-sensitivity in rat tail artery smooth muscle independent of guanylyl cyclase activation J. Vasc. Res. 33 1996 43
2. i in vascular smooth muscle by inhibition of the calcium current Cell Calcium 15 1994 122-131
3. Archer S. Huang J. Hample V. Nelson D. et al. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channels by cGMP-dependent protein kinase Proc. Natl. Acad. Sci. U.S.A. 91 1994 7583-7587
4. Bolotina V. Palacino J. et al. Nitric oxide directly activates calcium-dependent K-channels in vascular smooth muscle Nature 386 1994 850-853
5. 2+ in glomus cells of the rabbit carotid body via a cGMP-independent mechanism J. Neurophysiol. 81 1999 1449-1457
6. Sato K. Ozaki H. Karaki H. Changes in cytosolic calcium level in vascular smooth muscle strip measured simultaneously with contraction using fluorescent calcium indicator Fura-2 J. Pharmacol. Exp. Ther. 246 1988 294-300
7. 2+ level and contraction in vascular smooth muscle J. Pharmacol. Exp. Ther. 249 1989 895-900
8. Lehen'kyi V. Zelensky S. Stefanov A. Soloviev A. Effects of nitric oxide donors on vascular smooth muscle depend on a type of vascular smooth muscle preactivation Cardiovasc. Toxicol. 2 2002 151-160
9. Hashitani H. Fukuta H. Dickens E.J. Suzuki H. Cellular mechanisms on nitric oxide-induced relaxation of corporeal smooth muscle in the guinea-pig J. Physiol. 538 2002 573-581
10. Sommer D. Coleman S. Swanson S.A. Stemmer P.M. Different susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress Arch. Biochem. Biophys. 404 2002 271-278
11. Nishimura J. van Breemen K. Direct regulation of smooth muscle contractile elements by second messengers Biochem. Biophys. Res. Commun. 163 1989 929-935
12. i and uncoupling stress from myosin phosphorylation Am. J. Physiol. 263 1992 C461-C467
13. 2+ indicators with greatly improved fluorescent properties J. Biol. Chem. 260 1985 3440-3450
14. Arner A. Hellstrand P. Effect of calcium and substrate on force-velocity relation and energy turnover in skinned smooth muscle of the guinea pig J. Physiol. (London) 360 1985 347-365
15. Honkanen R. Zwiller R. Moore S. et al. Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A phosphatases J. Biol. Chem. 265 1990 19401-19404
16. Chung S.J. Fung H.L. Identification of the subcellular sites for nitroglycerin metabolism to nitric oxide in bovine coronary smooth muscle cells J. Pharmacol. Exp. Ther. 253 1990 614-619
17. Lincoln T. Kamalavilas P. Cornvell T. Pleotropic regulation of vascular muscle tone by cyclic GMP-dependent protein kinase Hypertension 23 part 2 1994 1141-1147
18. Kitazawa T. Masuo M. Somlyo A.P. G-protein mediated inhibition of myosin light chain phosphatase in vascular smooth muscle Proc. Natl. Acad. Sci. U.S.A. 88 20 1991 9307-9310
19. 2+ sensitivity Can. J. Physiol. Pharmacol. 72 11 1994 1420-1426
20. 2+ during agonist activation of permeabilized arteries Am. J. Physiol. 263 2 Pt1 1992 C540- C544
21. 2+-sensitivity in pig coronary arterial smooth muscle Biochem. Biophys. Res. Commun. 212 2 1995 572-579
22. Kanagy N.L. Webb R.C. Enhanced vascular reactivity to mastoparan, a G-protein activator, in genetical hypertensive rats Hypertension 23 6 Pt 2 1994 946-950
23. Gong M. Cohen T. Kitazava M. et al. Myosin light chain phosphatase activities and the effects of phosphatase inhibitors in tonic and phasic smooth muscle J. Biol. Chem. 267 1992 14662-14668
24. Gopalkrishna R. Chen Z. Gundimeda U. Nitric oxide and nitric oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding J. Biol. Chem. 268 36 1993 27180-27185
25. 2+-sensitivity in rabbit arterial skinned muscle Br. J. Pharmacol. 111 1 1994 311-317
26. Chatterjee M. Tejada M. Phorbol ester-induced contraction in chemically skinned vascular smooth muscle Am. J. Physiol. 251 1986 C356-C361